Details
Structure visualisation
Entry information
| Complex | |
| AACDB_ID: | 2471 |
| PDBID: | 6MHR |
| Chains: | DE_F |
| Organism: | Homo sapiens |
| Method: | XRD |
| Resolution (Å): | 2.80 |
| Reference: | 10.1038/s41467-018-07136-7 |
| Antibody | |
| Antibody: | Urelumab Fab |
| Antibody mutation: | No |
| INN (Clinical Trial): | Urelumab(Phase-II) |
| Antigen | |
| Antigen: | Tumor necrosis factor receptor superfamily member 9 (CD137) |
| Antigen mutation: | No |
| Durg Target: | Q07011 |
Sequence information
Antibody
Heavy Chain: D
Mutation: NULL
| >6MHR_D|Chain A, C[auth D]|Urelumab Fab heavy chain|Homo sapiens (9606) QVQLQQWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQSPEKGLEWIGEINHGGYVTYNPSLESRVTISVDTSKNQFSLKLSSVTAADTAVYYCARDYGPGNYDWYFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCAAAHHHHHHHH |
Light Chain: E
Mutation: NULL
| >6MHR_E|Chain B, D[auth E]|Urelumab Fab kappa chain|Homo sapiens (9606) EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPALTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC |
Antigen
Chain: F
Mutation: NULL
| >6MHR_F|Chain E[auth C], F|Tumor necrosis factor receptor superfamily member 9|Homo sapiens (9606) QDPCSNCPAGTFCDNNRNQICSPCPPNSFSSAGGQRTCDICRQCKGVFRTRKECSSTSNAECDCTPGFHCLGAGCSMCEQDCKQGQELTKKGCKDCCFGTFNDQKRGICRPWTNCSLDGKSVLVNGTKERDVVCGPSPENLYFQ |
Interaction
1、Solvent accessible surface areas (SASA) were calculated (Naccess V2.1.1) for each residue in antibody and antigen, respectively. The residues with SASA loss in binding of more than 1Å2 were classified as interacting residues.
Interacting residues (ΔSASA based)
| D: TYR33 GLU50 ASN52 TYR56 VAL57 THR58 GLY102 ASN103 TYR104 ASP105 TRP106 E: SER30 TYR32 ASP50 ARG91 ASN93 TRP94 PRO96 F: GLN25 ASP26 PRO27 CYS28 ASN30 PRO32 THR35 ASN39 ASN40 ARG41 ASN42 GLN43 ILE44 CYS45 ARG60 |
2、We defined interacting paratope-epitope residues by a distance cutoff of < 5Å . Two amino acids are considered as interacting residues if they have at least one atom within a distance of 5 Å from any atom.
Interacting residues (Atom distance based)
